Skip to content

Zimmer Biomet Holdings ZBH Global Dental — Goodwill Impairment

Discontinued — last reported Q4 '20

Similar metrics at other companies

DaVita logo
DVADE — Goodwill Impairment
$78.44M
Henry Schein logo
HSICGlobal Specialty Products — Goodwill And Intangible Asset Impairment
$3.25M
Henry Schein logo
HSICGlobal Distribution And Value Added Services — Goodwill Impairment
$0
Henry Schein logo
HSICGlobal Specialty Products — Goodwill Impairment
$2.75M
Leidos Holdings logo
LDOSHealth — Goodwill impairment charges
$0
DaVita logo
DVAInternational Operations — Goodwill Impairment
$375K

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.02B-21.5%
Enterprise value$24.07B-12.7%
P/E22.4×-1.4×
P/S-0.8×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Zimmer Biomet Holdings’s 10-K, filed February 25, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What does global dental — goodwill impairment mean?
The amount of value written off from the dental segment's goodwill due to a decline in its estimated fair market value.
How do you interpret global dental — goodwill impairment?
An increase indicates a deterioration in the long-term growth prospects or profitability of the dental business, suggesting that previous acquisition premiums were overvalued.
How does global dental — goodwill impairment compare across companies?
Peers in the medical device and dental sectors periodically report impairment charges during restructuring or when specific business units underperform relative to initial acquisition projections.